tradingkey.logo

Clearpoint Neuro Inc

CLPT
查看详细走势图
14.020USD
-0.470-3.24%
收盘 12/26, 16:00美东报价延迟15分钟
398.56M总市值
亏损市盈率 TTM

Clearpoint Neuro Inc

14.020
-0.470-3.24%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-3.24%

5天

-1.27%

1月

-2.91%

6月

+18.81%

今年开始到现在

-8.84%

1年

-10.98%

查看详细走势图

TradingKey Clearpoint Neuro Inc股票评分

单位: USD 更新时间: 2025-12-26

操作建议

Clearpoint Neuro Inc当前公司基本面数据相对健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名84/207位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价29.00。中期看,股价处于下降通道。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Clearpoint Neuro Inc评分

相关信息

行业排名
84 / 207
全市场排名
218 / 4563
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 2 位分析师
买入
评级
29.000
目标均价
+111.83%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Clearpoint Neuro Inc亮点

亮点风险
ClearPoint Neuro, Inc. is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. Its flagship product is the ClearPoint Neuro Navigation System. The Company is engaged with healthcare and research centers in North America, Europe, Asia, and South America. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. Its ClearPoint Prism Neuro Laser Therapy System is indicated for use to necrotize or coagulate soft tissue through interstitial irradiation or thermal therapy for neuro applications under 3.0T magnetic resonance imaging (MRI) guidance. The Company also provides solutions for direct CNS delivery of therapeutics in preclinical studies and clinical trials worldwide.
业绩高增长
公司营业收入稳步增长,连续3年增长52.74%
业绩增长期
公司处于发展阶段,最新年度总收入31.39M美元
利润高增长
公司净利润处于行业前列,最新年度总收入31.39M美元
估值低估
公司最新PE估值-16.96,处于3年历史低位
机构减仓
最新机构持股11.91M股,环比减少0.01%
景顺投资公司持仓
明星投资者景顺投资公司持仓,最新持仓市值8.12K
活跃度降低
近期活跃度降低,过去20天平均换手率0.61

Clearpoint Neuro Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Clearpoint Neuro Inc简介

ClearPoint Neuro, Inc. is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. Its flagship product is the ClearPoint Neuro Navigation System. The Company is engaged with healthcare and research centers in North America, Europe, Asia, and South America. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. Its ClearPoint Prism Neuro Laser Therapy System is indicated for use to necrotize or coagulate soft tissue through interstitial irradiation or thermal therapy for neuro applications under 3.0T magnetic resonance imaging (MRI) guidance. The Company also provides solutions for direct CNS delivery of therapeutics in preclinical studies and clinical trials worldwide.
公司代码CLPT
公司Clearpoint Neuro Inc
CEOBurnett (Joseph Michael)
网址https://www.clearpointneuro.com/

常见问题

Clearpoint Neuro Inc(CLPT)的当前股价是多少?

Clearpoint Neuro Inc(CLPT)的当前股价是 14.020。

Clearpoint Neuro Inc的股票代码是什么?

Clearpoint Neuro Inc的股票代码是CLPT。

Clearpoint Neuro Inc股票的52周最高点是多少?

Clearpoint Neuro Inc股票的52周最高点是30.100。

Clearpoint Neuro Inc股票的52周最低点是多少?

Clearpoint Neuro Inc股票的52周最低点是9.760。

Clearpoint Neuro Inc的市值是多少?

Clearpoint Neuro Inc的市值是398.56M。

Clearpoint Neuro Inc的净利润是多少?

Clearpoint Neuro Inc的净利润为-18.91M。

现在Clearpoint Neuro Inc(CLPT)的股票是买入、持有还是卖出?

根据分析师评级,Clearpoint Neuro Inc(CLPT)的总体评级为买入,目标价格为29.000。

Clearpoint Neuro Inc(CLPT)股票的每股收益(EPS TTM)是多少

Clearpoint Neuro Inc(CLPT)股票的每股收益(EPS TTM)是-0.827。
KeyAI